Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial.

Adigweme, Ikechukwu; Futa, Ahmed; Saidy-Jah, Ebrima; Edem, Bassey; Akpalu, Edem; Dibbasey, Tida; Sethna, Vistasp; Dhere, Rajeev; Kampmann, Beate; Bengt, Christopher; +7 more... Sirr, Jake; Hosken, Nancy; Goldblatt, David; Antony, Kalpana; Alderson, Mark R; Lamola, Steve; Clarke, Ed; (2023) Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial. The Lancet Infectious Diseases, 23 (5). pp. 609-620. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(22)00734-4

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(22)00734-4

Abstract

Share

Download

Filename: 1-s2.0-S1473309922007344-main.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar